Neurodevelopmental Outcomes in Children with Exposure to Prescription Stimulants During Pregnancy
Prenatal exposure to prescription stimulants was not associated with an increased risk of neurodevelopmental disorders in exposed children.
Prenatal exposure to prescription stimulants was not associated with an increased risk of neurodevelopmental disorders in exposed children.
Prenatal exposure to ADHD medications, mostly methylphenidate, was not associated with an increased risk of neurodevelopmental disorders or growth restriction in exposed children.
According to a report published by the CDC in Morbidity and Mortality Weekly Report (MMWR), the use of stimulant medications for the treatment of attention-deficit/hyperactivity disorder (ADHD) by reproductive-age women is on the rise. In [...]
For women with mild to moderate attention-deficit/hyperactivity disorder (ADHD) symptoms, we often recommend discontinuing stimulant medications and switching to a non-pharmacologic intervention. Many women experience some decrease in their level of functioning; however, they are [...]